Journal of Kidney Cancer and Vhl
Overview
Journal of Kidney Cancer and Vhl is a scientific journal, published since 2014 in English. The journal's country of origin is Australia.
Details
Details
Abbr.
J Kidney Cancer VHL
Start
2014
End
Continuing
Frequency
Quarterly, 2015-
e-ISSN
2203-5826
Country
Australia
Language
English
Recent Articles
21.
Kawabata T, Iguchi T, Matsui Y, Tomita K, Uka M, Umakoshi N, et al.
J Kidney Cancer VHL
. 2024 Jul;
11(2):39-42.
PMID: 39027141
A 50-year-old man with von Hippel-Lindau disease underwent cryoablation (CRA) for two adjacent renal cell carcinomas in the upper pole of his right kidney. Although computed tomography (CT) immediately after...
22.
Beecroft N, Gauntner T, Upadhyay R, Wang S, Yang Y, Singer E, et al.
J Kidney Cancer VHL
. 2024 Jun;
11(2):27-38.
PMID: 38863736
Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with a variable clinical course. While therapies for treatment of this condition have progressed, they are not without toxicity. In some...
23.
Singh V, Sarma D, Agarwal S, Bagchi P, Phukan M, Das N, et al.
J Kidney Cancer VHL
. 2024 May;
11(2):18-26.
PMID: 38799379
To analyze and compare the intraoperative and post-operative outcomes of "on-clamp" laparoscopic partial nephrectomy (LPN) with "preoperative super-selective angioembolization" before LPN. This randomized clinical study was conducted at Gauhati Medical...
24.
Javadi S, Habibi S, Sedaghat A, Naseripour M, Yousefi M
J Kidney Cancer VHL
. 2024 May;
11(2):12-17.
PMID: 38779573
This study aimed to assess the prevalence of neurological symptoms and related imaging findings in patients with von Hippel-Lindau (VHL) at Rasool Akram Hospital from September 2018 to September 2021....
25.
Survase P, Agrawal S, Singh A, Sabnes R, Desai M
J Kidney Cancer VHL
. 2024 May;
11(2):7-11.
PMID: 38779572
The immunosuppression administered to renal transplant recipients to safeguard renal function elevates their susceptibility to renal cancer, which is estimated to be 15 times higher than in the general population....
26.
Survase P, Agrawal S, Singh A, Sabnes R, Desai M
J Kidney Cancer VHL
. 2024 May;
11(1):69-73.
PMID: 38765864
The immunosuppression administered to renal transplant recipients to safeguard renal function elevates their susceptibility to renal cancer, which is estimated to be 15 times higher than in the general population....
27.
Demurtas S, Frascaroli M, Sottotetti F, Rametta A, Procopio G, Locati L
J Kidney Cancer VHL
. 2024 Apr;
11(2):1-6.
PMID: 38628557
Clear cell renal carcinoma (ccRCC) can occur in young people and could be associated with an aggressive behavior. While for the first-line treatment in metastatic disease, there is an agreement...
28.
Bak R, Jensen J, Pelant T, Haase R, Nielsen T
J Kidney Cancer VHL
. 2024 Apr;
11(1):54-62.
PMID: 38567125
Small renal masses (SRMs) are often benign or early-stage cancers with low metastatic potential. The risk of overtreating SRMs is a particular concern in elderly or comorbid patients, for whom...
29.
Olmstead T, Emmerling M, Bantumilli S, Raynor M, Nielsen M, Bjurlin M, et al.
J Kidney Cancer VHL
. 2024 Mar;
11(1):49-53.
PMID: 38464887
The use of prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is becoming more widespread for the diagnosis and management of prostate cancer. Here we report a case of oligometastatic renal cell...
30.
Al-Ezzi E, Mittal A, Veitch Z, Zahralliyali A, Mejia N, Abdeljalil O, et al.
J Kidney Cancer VHL
. 2024 Mar;
11(1):41-48.
PMID: 38450000
Immunotherapy (IO) with or without targeted therapy (TT) is the standard treatment for patients with metastatic clear cell renal cell carcinoma (RCC). The evidence supporting their use in metastatic nonclear...